Component

Acrolein

Context-specific entity; species, compartment and exposure are stated on each claim.

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

Read recorded mechanisms Open recursive mind map

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

Where it participates (unsigned role)

  1. Oral octyl-D-carnosine reduced aortic-valve lesions and lesion aldehyde-protein adducts in Apoe-null mice.

    Octyl-D-carnosine, synthetic derivative → Mouse Apoe-null aortic-valve lesions source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Apoe-null mouse feeding experiment.
    limitations
    The administered compound was an analog, not ordinary L-carnosine; no human efficacy inferred.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    A synthetic derivative showed an effect in a mouse disease model.
    primary_references
    Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23559625/ · DOI 10.1161/ATVBAHA.112.300572

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 332–338

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Apoe-null mouse feeding experiment. · source_derived_draft · unverified_draft

    ## carnosine-analog-atheroma A synthetic derivative showed an effect in a mouse disease model. Oral octyl-D-carnosine reduced aortic-valve lesions and lesion aldehyde-protein adducts in Apoe-null mice. Model: Apoe-null mouse feeding experiment. Limitations: The administered compound was an analog, not ordinary L-carnosine; no human efficacy inferred. Evidence access: Primary abstract Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice. · 2013 · https://pubmed.ncbi.nlm.nih.gov/23559625/ · DOI 10.1161/ATVBAHA.112.300572
    Complete structured claim and evidence

  2. Oral carnosine increased urinary carnosine-acrolein adduct excretion, with substantial differences between individuals.

    L-Carnosine / beta-alanyl-L-histidine → Human urinary carnosine-acrolein adduct excretion source_derived_draftungraded
    Experimental context and source evidence
    evidence_access
    Primary abstract
    experimental_model
    Overweight adults; 2 g/day for twelve weeks.
    limitations
    Urinary adducts do not quantify total tissue detoxification; plasma carnosine/adducts were not detected.
    nutrient_topic
    Carnosine collection; isomer, preparation, species, exposure and manipulation remain explicit. · L-Carnosine / beta-alanyl-L-histidine
    plain_language
    Human urine provided evidence of aldehyde trapping.
    primary_references
    A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27265207/ · DOI 10.1038/srep27224

    Carnosine: synthesis, transport, carbonyl chemistry and nutrient interactions (2026-09-19) · lines 268–274

    AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Overweight adults; 2 g/day for twelve weeks. · source_derived_draft · unverified_draft

    ## carnosine-human-acrolein Human urine provided evidence of aldehyde trapping. Oral carnosine increased urinary carnosine-acrolein adduct excretion, with substantial differences between individuals. Model: Overweight adults; 2 g/day for twelve weeks. Limitations: Urinary adducts do not quantify total tissue detoxification; plasma carnosine/adducts were not detected. Evidence access: Primary abstract A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect. · 2016 · https://pubmed.ncbi.nlm.nih.gov/27265207/ · DOI 10.1038/srep27224
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards